Exosomes extracted from glioblastoma patients’ plasma also included TrkB (Tropomyosin receptor kinase B) expression, suggesting that this receptor might be employed as a biomarker for glioblastoma diagnosis (Kimura et al., 2019). This evidence concerns the gene NTRK2 and glioblastoma.